Will Patient RWD Improve Cardiovascular Disease Outcomes?

Amgen and Datos Health have partnered to explore how RWD (real world data) can improve outcomes for heart disease patients. Using apps, the companies are tracking medication adherence along with patient vitals and daily exercise routines. By monitoring patients more closely, the overall goal is to improve patient care and to reduce the risk of heart attacks and heart failure.

Datos Health CEO Uri Bettesh remarks, “How can we harness digital therapeutics with drugs and how can we reach the best outcome for patients using these tools? And not only looking at drug adherence,” adding,”Doctors (can) make better decisions on an individual patient’s health and especially on their medication.” Read more here.

(Source: Beth Snyder Bulik, Fierce Pharma, 4/23/21)